皮肤癣菌病的治疗：安全性考量 - Suppr

Suppr

超能文献

The treatment of dermatophytosis: safety considerations.

作者信息

Smith E B

机构信息

Department of Dermatology, University of New Mexico School of Medicine, Albuquerque 87110, USA.

出版信息

J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S113-9. doi: 10.1067/mjd.2000.110379.

DOI:10.1067/mjd.2000.110379

PMID:11044286

Abstract

摘要

相似文献

The treatment of dermatophytosis: safety considerations.

J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S113-9. doi: 10.1067/mjd.2000.110379.

The use of oral antifungal agents to treat onychomycosis.

Dermatol Clin. 2003 Jul;21(3):469-79, vi. doi: 10.1016/s0733-8635(03)00027-5.

Dermatophytosis: the management of fungal infections.

Skinmed. 2005 Sep-Oct;4(5):305-10. doi: 10.1111/j.1540-9740.2005.03435.x.

Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.

Eur J Dermatol. 2005 Jul-Aug;15(4):258-61.

New oral treatments for dermatophytosis.

Ann N Y Acad Sci. 1988;544:580-5. doi: 10.1111/j.1749-6632.1988.tb40456.x.

An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.

Int J Dermatol. 2000 Jun;39(6):401-11. doi: 10.1046/j.1365-4362.2000.00964.x.

New antifungal therapy for children.

Adv Dermatol. 1997;12:195-208; discussion 209.

The use of systemic antimycotics in dermatotherapy.

Eur J Dermatol. 2000 Mar;10(2):155-60.

Overview: The treatment of dermatophytosis.

J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S104-12. doi: 10.1067/mjd.2000.110380.

Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.

Dermatology. 2001;202(3):235-8. doi: 10.1159/000051643.

引用本文的文献

Dermacase. Dermatophyte infection (tinea).

Can Fam Physician. 2005 Apr;51(4):499-501.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The treatment of dermatophytosis: safety considerations.

J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S113-9. doi: 10.1067/mjd.2000.110379.

The use of oral antifungal agents to treat onychomycosis.

Dermatol Clin. 2003 Jul;21(3):469-79, vi. doi: 10.1016/s0733-8635(03)00027-5.

Dermatophytosis: the management of fungal infections.

Skinmed. 2005 Sep-Oct;4(5):305-10. doi: 10.1111/j.1540-9740.2005.03435.x.

Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.

Eur J Dermatol. 2005 Jul-Aug;15(4):258-61.

New oral treatments for dermatophytosis.

Ann N Y Acad Sci. 1988;544:580-5. doi: 10.1111/j.1749-6632.1988.tb40456.x.

An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.

Int J Dermatol. 2000 Jun;39(6):401-11. doi: 10.1046/j.1365-4362.2000.00964.x.

New antifungal therapy for children.

Adv Dermatol. 1997;12:195-208; discussion 209.

The use of systemic antimycotics in dermatotherapy.

Eur J Dermatol. 2000 Mar;10(2):155-60.

Overview: The treatment of dermatophytosis.

J Am Acad Dermatol. 2000 Nov;43(5 Suppl):S104-12. doi: 10.1067/mjd.2000.110380.

Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.

Dermatology. 2001;202(3):235-8. doi: 10.1159/000051643.

引用本文的文献

Dermacase. Dermatophyte infection (tinea).

Can Fam Physician. 2005 Apr;51(4):499-501.